MEDEZE Partners with IFCG, Signing MOU to Expand Sales Network Targeting High-Purchasing Power Clients
MEDEZE Group joins forces with IFCG, a leading business and investment consultancy in Thailand, to sign a Memorandum of Understanding (MOU) to expand MEDEZE’s network of consultants by adding over 400 representatives and granting access to IFCG’s client base of more than 50,000 high-purchasing-power individuals.
Dr. Veerapol Kemarangsan, Chief Executive Officer of MEDEZE Group Public Company Limited (MEDEZE), revealed that the company has signed an MOU with IFCG Public Company Limited (IFCG), a leading business and investment consultant in Thailand. The partnership will expand MEDEZE’s distribution network for consulting and offering services related to stem cell collection, analysis, storage, and cultivation, including cells derived from umbilical cords, adult fat tissue, and hair follicles. Marking a leap in MEDEZE’s footprint.
Currently, MEDEZE has a team of has approximately 50 consultants, which will increase to over 400 from IFCG. Most importantly, this expansion will enable MEDEZE to effectively penetrate the high-purchasing-power segment—an essential target group where IFCG already has extensive experience and expertise in serving more than 50,000 clients.
“MEDEZE will be able to reach a new client base with significant purchasing power. Collaborating with a partner that boasts such a vast customer network will accelerate our market expansion and increase opportunities in new markets especially among those interested in cutting-edge hair follicle stem cells technology” Dr. Veerapol said.
Mr. Withoon lertpanomwan, CEO of IFCG Public Company Limited, highlighted IFCG’s long history as leading company in business and investment consultancy in Thailand. With expertise and long legacy of serving more than 50,000 clients through over 400 experts, IFCG delivers unbiased advice supported by cutting-edge innovation and a diverse range of financial and investment solutions tailored for every needs securely and sustainably.
This MOU is set to provide substantial benefits to the clients of both MEDEZE and IFCG. MEDEZE clients will gain access to IFCG’s advisory network, while IFCG’s will benefit from effective and diverse consultancy on MEDEZE’s expertise in stem cell analysis, cultivation, storage, and immune cell testing.
IR Press Releases